June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Role of proNGF/p75NTR mediated RhoA activation in diabetes-induced BRB breakdown
Author Affiliations & Notes
  • Barbara Mysona
    UGA Clinical and Experimental Therapeutics, University of Georgia, Augusta, GA
    Vision Discovery Institute, Georgia Health Sciences University, Augusta, GA
  • Suraporn Matragoon
    UGA Clinical and Experimental Therapeutics, University of Georgia, Augusta, GA
  • Azza El-Remessy
    UGA Clinical and Experimental Therapeutics, University of Georgia, Augusta, GA
    Vision Discovery Institute, Georgia Health Sciences University, Augusta, GA
  • Footnotes
    Commercial Relationships Barbara Mysona, None; Suraporn Matragoon, None; Azza El-Remessy, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 2699. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Barbara Mysona, Suraporn Matragoon, Azza El-Remessy; Role of proNGF/p75NTR mediated RhoA activation in diabetes-induced BRB breakdown. Invest. Ophthalmol. Vis. Sci. 2013;54(15):2699. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Diabetic macular edema is characterized by early breakdown of the inner blood-retinal barrier (BRB). Understanding the mechanism of this breakdown is essential for developing alternative therapies to laser photocoagulation and anti-VEGF injections. Previously, we have shown that modulation of p75NTR expression prevents diabetes- and proNGF-induced retinal inflammation and BRB breakdown. Increased activation of RhoA has also been demonstrated in diabetic and proNGF overexpressing retinas. We hypothesize that diabetes-induced proNGF stimulates p75NTR dependent activation of RhoA in endothelial cells leading to barrier dysfunction.

Methods: Inhibition of Rho-kinase using intravitreal injection of Y-27632 (100 nmole/eye) was employed in streptozotocin (STZ) induced diabetic male Sprague-Dawley rats and in proNGF overexpressing rats. BRB breakdown was assayed by extravasation of BSA-conjugated fluorescein. Barrier function of confluent human retinal endothelial (HRE) cells treated with human mutant proNGF (10, 20, 50 ng/ml) was assessed by electrical cell-substrate impedance sensing machine (ECIS) in presence or absence of Y-27632 (10 μM) or gamma-secretase inhibitor (compound E, 10 μM). Protein expression was analyzed by western blot.

Results: Inhibition of Rho kinase significantly decreased BRB breakdown in retinas after 5 weeks STZ-diabetes and after 1-week proNGF overexpression. In vitro, mutant proNGF induced dose-dependent HRE cell permeability which was blocked by inhibition of Rho-kinase or p75NTR cleavage. ProNGF treatment was accompanied by decreased expression of tight junction proteins ZO-1 and claudin-5 compared to controls.

Conclusions: Our data support a novel role for proNGF/p75NTR in activating RhoA mediated endothelial cell permeability and BRB breakdown in early diabetes. The p75NTR/Rho kinase pathway may be a potential therapeutic target in the diabetic retina.

Keywords: 499 diabetic retinopathy • 446 cell adhesions/cell junctions • 674 receptors  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×